Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
5.91
Dollar change
+0.37
Percentage change
6.68
%
Index- P/E- EPS (ttm)-15.10 Insider Own0.00% Shs Outstand2.23M Perf Week-10.86%
Market Cap13.18M Forward P/E- EPS next Y-7.42 Insider Trans- Shs Float2.15M Perf Month-35.40%
Income-29.77M PEG- EPS next Q-3.53 Inst Own15.51% Short Float0.10% Perf Quarter-44.51%
Sales0.00M P/S- EPS this Y23.42% Inst Trans- Short Ratio0.07 Perf Half Y-2.69%
Book/sh11.70 P/B0.50 EPS next Y35.70% ROA-62.25% Short Interest0.00M Perf Year-58.51%
Cash/sh10.56 P/C0.56 EPS next 5Y- ROE-76.07% 52W Range4.34 - 24.75 Perf YTD-54.10%
Dividend Est.- P/FCF- EPS past 5Y18.25% ROI-112.14% 52W High-76.12% Beta1.95
Dividend TTM- Quick Ratio3.86 Sales past 5Y0.00% Gross Margin- 52W Low36.18% ATR (14)1.00
Dividend Ex-Date- Current Ratio3.86 EPS Y/Y TTM0.81% Oper. Margin0.00% RSI (14)38.47 Volatility20.38% 13.49%
Employees18 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price30.00
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q-44.51% Payout- Rel Volume2.55 Prev Close5.54
Sales Surprise- EPS Surprise-55.66% Sales Q/Q- EarningsMar 22 AMC Avg Volume30.46K Price5.91
SMA20-26.68% SMA50-25.36% SMA200-29.64% Trades Volume77,685 Change6.68%
Date Action Analyst Rating Change Price Target Change
Jul-18-22Resumed Oppenheimer Outperform $14
Today 10:45AM
Mar-27-24 09:25AM
09:05AM
Mar-26-24 08:36AM
Mar-25-24 07:30AM
08:52PM Loading…
Mar-22-24 08:52PM
05:31PM
04:05PM
Mar-20-24 07:30AM
Mar-19-24 04:30PM
Mar-12-24 09:05AM
Jan-24-24 08:50AM
Dec-20-23 09:16PM
Dec-11-23 08:50AM
Nov-14-23 01:46PM
10:29AM Loading…
10:29AM
Nov-13-23 08:05AM
08:00AM
Nov-07-23 08:45AM
Nov-06-23 08:35AM
Oct-24-23 07:45AM
Oct-18-23 10:00AM
Oct-11-23 09:05AM
Oct-02-23 08:40AM
Sep-22-23 07:58AM
Sep-21-23 08:50AM
Sep-18-23 08:40AM
Sep-14-23 08:35AM
Sep-05-23 08:35AM
Aug-12-23 12:16AM
06:45AM Loading…
Aug-11-23 06:45AM
Aug-10-23 04:05PM
Aug-07-23 08:40AM
Aug-03-23 08:45AM
Jul-13-23 08:40AM
Jul-06-23 08:45AM
Jun-13-23 08:35AM
May-30-23 09:05AM
May-12-23 11:15AM
May-11-23 08:04AM
07:05AM
May-10-23 04:05PM
May-04-23 08:35AM
May-02-23 08:35AM
Apr-24-23 09:55AM
Apr-18-23 05:33PM
01:35PM
Mar-27-23 12:00PM
06:26AM
Mar-24-23 05:33AM
Mar-23-23 07:10AM
Mar-22-23 04:20PM
Mar-21-23 08:50AM
Mar-15-23 08:30AM
Mar-13-23 08:35AM
07:05AM
Mar-09-23 08:35AM
Mar-01-23 08:45AM
Feb-13-23 11:30AM
08:10AM
Jan-11-23 01:00PM
Jan-05-23 08:45AM
Dec-21-22 08:25AM
Dec-19-22 09:15AM
Dec-15-22 01:09PM
08:35AM
Dec-07-22 08:45AM
Nov-14-22 05:23PM
Nov-10-22 04:05PM
Nov-07-22 09:05AM
Oct-14-22 08:40AM
Sep-27-22 01:01PM
08:35AM
Sep-23-22 09:11AM
Sep-08-22 08:45AM
Sep-07-22 08:35AM
Sep-06-22 08:45AM
Aug-19-22 08:40AM
Aug-15-22 08:35AM
Jul-28-22 08:35AM
Jul-11-22 10:22AM
Jul-08-22 08:35AM
Jun-16-22 08:35AM
May-26-22 08:35AM
May-19-22 08:05AM
May-12-22 08:35AM
May-10-22 08:35AM
May-05-22 08:15AM
May-04-22 08:15AM
Apr-21-22 08:47AM
Apr-14-22 08:05AM
Apr-11-22 07:05AM
Apr-08-22 01:05PM
Mar-25-22 07:05AM
Mar-23-22 08:05AM
Mar-11-22 08:05AM
Mar-01-22 08:35AM
Feb-14-22 02:10PM
09:05AM
Feb-01-22 09:11AM
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KLEMP WALTER VCEO and PresidentDec 26 '23Buy0.69188,404129,999680,880Dec 27 07:31 AM
Foster Jonathan P.Chief Financial OfficerDec 26 '23Buy0.6928,98620,00080,556Dec 27 07:32 AM
George Robert E.DirectorDec 26 '23Buy0.6914,49310,00014,660Dec 27 07:31 AM